AstraZeneca expands Guadalajara center to foster collaboration and innovation in biopharma
Global biopharmaceutical giant AstraZeneca will invest 600 million pesos (approximately US$30 million) this year to expand its Global Center for Innovation and Technology (GITC) in Guadalajara.